Yıl: 2021 Cilt: 51 Sayı: 3 Sayfa Aralığı: 134 - 138 Metin Dili: Türkçe DOI: 10.4274/tjo.galenos.2020.88137 İndeks Tarihi: 14-06-2022

Graft Versus Host Hastalığı ile İlişkili Pediatrik Kuru Gözde Oküler Bulgular

Öz:
Amaç: Pediatrik hematopoetik kök hücre nakli (HKHN) yapılan hastalarda gelişen oküler graft versus host hastalığının (GVHH) sıklığını ve bulgularını incelemek. Gereç ve Yöntem: Oküler GVHH tanısı alan pediatrik hastaların dosyaları retrospektif olarak incelendi ve bu hastaların Schirmer testi, gözyaşı kırılma zamanı ve korneal boyanma derecelenmesini içeren muayene bulguları kaydedildi. Ciddi kuru gözü olan hastalara topikal siklosporin-A başlandı ve tedavinin sonuçları değerlendirildi. Bulgular: HKHN yapılan 218 hastadan 51’inde (%23,4) GVHH tespit edildi ve bu hastaların 4’ü takipleri sırasında hayatını kaybetti. Takip edilen toplam 47 hastanın %63,8’inde kronik oküler GVHH tespit edildi ve 4 hastaya ortanca takip süresi 12,1 ay olmak üzere ciddi kuru göz bulguları nedeniyle topikal siklosporin-A tedavisi uygulandı. İki hastada ciddi kuru göz bulgularında belirgin bir düzelme izlenirken, 1 hastada ilaç yan etkisi nedeniyle tedavinin kesilmesi gerekti. Sonuç: Kronik oküler GVHH, çocuklarda HKHN sonrası gelişen GVHH’nin sık izlenen bir bulgusudur. Bu nedenle, bu hastaların kuru göz açısından belirli aralıkla muayene edilmesi gerekmektedir.
Anahtar Kelime:

Ocular Findings of Pediatric Dry Eye Related to Graft-Versus-Host Disease

Öz:
Objectives: To evaluate the frequency and findings of dry eye associated with ocular graft-versus-host disease (GVHD) in pediatric hematopoietic stem cell transplantation (HSCT) patients. Materials and Methods: Retrospectively the records of pediatric patients with ocular GVHD were evaluated and ophthalmologic examination findings as well as Schirmer test results, tear film break-up time, and corneal staining grades were recorded. In severe dry eye patients topical cyclosporine-A was prescribed and the results were evaluated. Results: GVHD was detected in 51 (23.4%) of 218 HSCT patients, 4 of whom died during follow-up. Thirty (63.8%) of the remaining 47 patients had chronic ocular GVHD and 4 patients with severe dry eye were treated with topical cyclosporine-A with a median follow-up of 12.1 months. Severe dry eye symptoms and findings significantly improved in 2 patients. However, 1 patient had to stop treatment due to side effects. Conclusion: In children, chronic ocular GVHD is a common finding of GVHD after HSCT. Therefore, these patients should be examined periodically for dry eye.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Strocchio L, Locatelli F. Hematopoietic Stem Cell Transplantation in Thalassemia. Hematol Oncol Clin North Am. 2018;32:317-328.
  • 2. Kim H. Treatments for children and adolescents with AML. Blood Res. 2020;55(Suppl 1):5-13.
  • 3. Tan EY, Boelens JJ, Jones SA, Wynn RF. Hematopoietic Stem Cell Transplantation in Inborn Errors of Metabolism. Front Pediatr. 2019;7:433.
  • 4. Atkinson K. Bone marrow transplantation. Med J Aust. 1992;157:408-411.
  • 5. Shikari H, Antin JH, Dana R. Ocular graft-versus-host disease: a review. Surv Ophthalmol. 2013;58:233-251.
  • 6. No authors listed. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5:75-92.
  • 7. Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003;22:640-650.
  • 8. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, Martin P, Chien J, Przepiorka D, Couriel D, Cowen EW, Dinndorf P, Farrell A, Hartzman R, Henslee-Downey J, Jacobsohn D, McDonald G, Mittleman B, Rizzo JD, Robinson M, Schubert M, Schultz K, Shulman H, Turner M, Vogelsang G, Flowers ME. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11:945-956.
  • 9. Franklin RM, Kenyon KR, Tutschka PJ, Saral R, Green WR, Santos GW. Ocular manifestations of graft-vs-host disease. Ophthalmology. 1983;90:4-13.
  • 10. Hirst LW, Jabs DA, Tutschka PJ, Green WR, Santos GW. The eye in bone marrow transplantation. I. Clinical study. Arch Ophthalmol. 1983;101:580-584.
  • 11. Zecca M, Prete A, Rondelli R, Lanino E, Balduzzi A, Messina C, Fagioli F, Porta F, Favre C, Pession A, Locatelli F; AIEOP-BMT Group. Chronic graftversus- host disease in children: incidence, risk factors, and impact on outcome. Blood 2002;100:1192-1200.
  • 12. Kondo M, Kojima S, Horibe K, Kato K, Matsuyama T. Risk factors for chronic graft-versus-host disease after allogeneic stem cell transplantation in children. Bone Marrow Transplant. 2001;27:727-730.
  • 13. Eisner MD, August CS. Impact of donor and recipient characteristics on the development of acute and chronic graft-versus-host disease following pediatric bone marrow transplantation. Bone Marrow Transplant. 1995;15:663-668.
  • 14. Bray LC, Carey PJ, Proctor SJ, Evans RG, Hamilton PJ. Ocular complications of bone marrow transplantation. Br J Ophthalmol. 1991;75:611-614.
  • 15. De Marco R, Dassio DA, Vittone P. A retrospective study of ocular side effects in children undergoing bone marrow transplantation. Eur J Ophthalmol. 1996;6:436-439.
  • 16. Suh DW, Ruttum MS, Stuckenschneider BJ, Mieler WF, Kivlin JD. Ocular findings after bone marrow transplantation in a pediatric population. Ophthalmology. 1999;106:1564-1570.
  • 17. Hoehn ME, Calderwood J, Gannon E, Cook B, Rochester R, Hartford C, Triplett B, Sunkara A, Kang G, Walton RC. Ocular complications in a young pediatric population following bone marrow transplantation. J AAPOS. 2018;22:102-106.
  • 18. Ng JS, Lam DS, Li CK, Chik KW, Cheng GP, Yuen PM, Tso MO. Ocular complications of pediatric bone marrow transplantation. Ophthalmology. 1999;106:160-164.
  • 19. Fahnehjelm KT, Törnquist AL, Winiarski J. Dry-eye syndrome after allogeneic stem-cell transplantation in children. Acta Ophthalmol. 2008;86:253-258.
  • 20. Westekemper H, Meller S, Citak S, Schulte C, Steuhl KP, Homey B, Meller D. Differential chemokine expression in chronic GVHD of the conjunctiva. Bone Marrow Transplant. 2010;45:1340-1346.
  • 21. Pflugfelder SC, Solomon A, Stern ME. The diagnosis and management of dry eye: a twenty-five-year review. Cornea. 2000;19:644-649.
  • 22. Pfau B, Kruse FE, Rohrschneider K, Zorn M, Fiehn W, Burk RO, Völcker HE. [Comparison between local and systemic administration of cyclosporin A on the effective level in conjunctiva, aqueous humor and serum]. Ophthalmologe. 1995;92:833-839.
  • 23. Sall K, Stevenson OD, Mundorf TK, Reis BL. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology. 2000;107:631-639.
  • 24. Wang Y, Ogawa Y, Dogru M, Kawai M, Tatematsu Y, Uchino M, Okada N, Igarashi A, Kujira A, Fujishima H, Okamoto S, Shimazaki J, Tsubota K. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease. Bone Marrow Transplant. 2008;41:293-302.
  • 25. Kiang E, Tesavibul N, Yee R, Kellaway J, Przepiorka D. The use of topical cyclosporin A in ocular graft-versus-host-disease. Bone Marrow Transplant. 1998;22: 147-151.
  • 26. Malta JB, Soong HK, Shtein RM, Musch DC, Rhoades W, Sugar A, Mian SI. Treatment of ocular graft-versus-host disease with topical cyclosporine 0.05%. Cornea. 2010;29:1392-1396.
  • 27. Stevenson D, Tauber J, Reis BL. Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group. Ophthalmology. 2000;107:967-974.
  • 28. Lelli GJ Jr, Musch DC, Gupta A, Farjo QA, Nairus TM, Mian SI. Ophthalmic cyclosporine use in ocular GVHD. Cornea. 2006;25:635-638.
APA Bingol Kiziltunc P, Çelik Büyüktepe T, YALÇINDAĞ F, Ertem M, ince e, İleri T, Atilla H (2021). Graft Versus Host Hastalığı ile İlişkili Pediatrik Kuru Gözde Oküler Bulgular. , 134 - 138. 10.4274/tjo.galenos.2020.88137
Chicago Bingol Kiziltunc Pinar,Çelik Büyüktepe Tuna,YALÇINDAĞ FATİME NİLÜFER,Ertem Mehmet,ince elif,İleri Talia,Atilla Huban Graft Versus Host Hastalığı ile İlişkili Pediatrik Kuru Gözde Oküler Bulgular. (2021): 134 - 138. 10.4274/tjo.galenos.2020.88137
MLA Bingol Kiziltunc Pinar,Çelik Büyüktepe Tuna,YALÇINDAĞ FATİME NİLÜFER,Ertem Mehmet,ince elif,İleri Talia,Atilla Huban Graft Versus Host Hastalığı ile İlişkili Pediatrik Kuru Gözde Oküler Bulgular. , 2021, ss.134 - 138. 10.4274/tjo.galenos.2020.88137
AMA Bingol Kiziltunc P,Çelik Büyüktepe T,YALÇINDAĞ F,Ertem M,ince e,İleri T,Atilla H Graft Versus Host Hastalığı ile İlişkili Pediatrik Kuru Gözde Oküler Bulgular. . 2021; 134 - 138. 10.4274/tjo.galenos.2020.88137
Vancouver Bingol Kiziltunc P,Çelik Büyüktepe T,YALÇINDAĞ F,Ertem M,ince e,İleri T,Atilla H Graft Versus Host Hastalığı ile İlişkili Pediatrik Kuru Gözde Oküler Bulgular. . 2021; 134 - 138. 10.4274/tjo.galenos.2020.88137
IEEE Bingol Kiziltunc P,Çelik Büyüktepe T,YALÇINDAĞ F,Ertem M,ince e,İleri T,Atilla H "Graft Versus Host Hastalığı ile İlişkili Pediatrik Kuru Gözde Oküler Bulgular." , ss.134 - 138, 2021. 10.4274/tjo.galenos.2020.88137
ISNAD Bingol Kiziltunc, Pinar vd. "Graft Versus Host Hastalığı ile İlişkili Pediatrik Kuru Gözde Oküler Bulgular". (2021), 134-138. https://doi.org/10.4274/tjo.galenos.2020.88137
APA Bingol Kiziltunc P, Çelik Büyüktepe T, YALÇINDAĞ F, Ertem M, ince e, İleri T, Atilla H (2021). Graft Versus Host Hastalığı ile İlişkili Pediatrik Kuru Gözde Oküler Bulgular. Türk Oftalmoloji Dergisi, 51(3), 134 - 138. 10.4274/tjo.galenos.2020.88137
Chicago Bingol Kiziltunc Pinar,Çelik Büyüktepe Tuna,YALÇINDAĞ FATİME NİLÜFER,Ertem Mehmet,ince elif,İleri Talia,Atilla Huban Graft Versus Host Hastalığı ile İlişkili Pediatrik Kuru Gözde Oküler Bulgular. Türk Oftalmoloji Dergisi 51, no.3 (2021): 134 - 138. 10.4274/tjo.galenos.2020.88137
MLA Bingol Kiziltunc Pinar,Çelik Büyüktepe Tuna,YALÇINDAĞ FATİME NİLÜFER,Ertem Mehmet,ince elif,İleri Talia,Atilla Huban Graft Versus Host Hastalığı ile İlişkili Pediatrik Kuru Gözde Oküler Bulgular. Türk Oftalmoloji Dergisi, vol.51, no.3, 2021, ss.134 - 138. 10.4274/tjo.galenos.2020.88137
AMA Bingol Kiziltunc P,Çelik Büyüktepe T,YALÇINDAĞ F,Ertem M,ince e,İleri T,Atilla H Graft Versus Host Hastalığı ile İlişkili Pediatrik Kuru Gözde Oküler Bulgular. Türk Oftalmoloji Dergisi. 2021; 51(3): 134 - 138. 10.4274/tjo.galenos.2020.88137
Vancouver Bingol Kiziltunc P,Çelik Büyüktepe T,YALÇINDAĞ F,Ertem M,ince e,İleri T,Atilla H Graft Versus Host Hastalığı ile İlişkili Pediatrik Kuru Gözde Oküler Bulgular. Türk Oftalmoloji Dergisi. 2021; 51(3): 134 - 138. 10.4274/tjo.galenos.2020.88137
IEEE Bingol Kiziltunc P,Çelik Büyüktepe T,YALÇINDAĞ F,Ertem M,ince e,İleri T,Atilla H "Graft Versus Host Hastalığı ile İlişkili Pediatrik Kuru Gözde Oküler Bulgular." Türk Oftalmoloji Dergisi, 51, ss.134 - 138, 2021. 10.4274/tjo.galenos.2020.88137
ISNAD Bingol Kiziltunc, Pinar vd. "Graft Versus Host Hastalığı ile İlişkili Pediatrik Kuru Gözde Oküler Bulgular". Türk Oftalmoloji Dergisi 51/3 (2021), 134-138. https://doi.org/10.4274/tjo.galenos.2020.88137